During the operation the hemodynamic changes were greater in group 2. The needs of adding ephydrine and atropine were 1 & 2 in group 1, and 9 & 5 in group 2. The starting time of urination of the transplanted kidney was earlier in group 1 than in group 2, being 209±25s and 410±47s, respectively(P<0. 001).
Objective To study the changes of the urinary α-1 microglobulin and urinary immunoglobulin G(IgG) and to investigate the relationship between these two proteins and the allograft function after renal transplantation.
Results The rate of chronic renal allograft rejection in the recipients with TGF-β1 high producer genotype [42.9% (39/91)] was significantly higher than that in those with TGF-β1 intermediate or low producer genotypes [17.0% (9/53)] (P<0.01).
While in the recipients with TGF-β1 intermediate or low producer genotypes, whose donors had TGF-β1 intermediate or low producer genotypes also, the rate of chronic renal allograft rejection (12/61, 19.7%)was significantly lower than that in other recipients (23/53, 43.4%, P<0.01).
Methods: Immunohistochemical technique was used to detect FasL and TIA-1 expression in 32 transplanted renal samples,2 living donor kidneys and 8 adjacent samples of renal cancer(including 14 acute rejection samples,15 chronic and 13 non-rejection ones according to Banff criteria).
The kinetics of human cytomegalovirus (HCMV)-specific immunoglobulin E (IgE), M (IgM), A (IgA) and G (IgG) were studied in 421 sera obtained from 19 renal allograft recipients by enzyme-linked immunosorbent assay (ELISA).
As shown by the present study, specific IgE proved to be a more reliable serologic marker than IgM and IgA for the serologic detection of HCMV infection in renal allograft recipients.
An HPLC-method for the measurement of blood Cyclosporin A levels (CyA) of renal allograft transplanted patients within 9min is described.
Renal allograft survival is closely connected with recipient blood pressure.
Because AT1-AA has been linked to an impaired uteroplacental perfusion and has been detected in patients with renal allograft rejection, its occurrence and function seem to be wider and more complex.